| Delårsrapport januari – september 2017 | Report (pdf) | |
| Delårsrapport januari – juni 2017 | Report (pdf) | |
| Listing on Nasdaq First North | Prospekt (pdf) | |
| Delårsrapport januari – mars 2017 | Report (pdf) | |
| Årsredovisning Juli 2015 – December 2016 | Report (pdf) | |
| Pergamum AB – Årsredovisning Juli 2015 – December 2016 | Report (pdf) |
The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.
To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.
To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.